[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Hormonal Therapy Industry Market Analysis & Forecast 2018-2023

June 2018 | 137 pages | ID: C002405582FEN
S&P Consulting

US$ 3,120.00 US$ 3,900.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the China Hormonal Therapy Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

The Major players reported in the market include:
Bayer HealthCare Pharmaceuticals Inc.
Besins Healthcare SA
Hisamitsu Pharmaceutical Co. Inc.
Noven Pharmaceuticals Inc., Mylan
Novartis AG, Novo Nordisk A/S
Orion Corp.
Pfizer Inc.
company 8
company 9

China Hormonal Therapy Market: Product Segment Analysis
Oncologic hormone therapy
Hormone replacement therapy
Type 3

China Hormonal Therapy Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
China Hormonal Therapy Industry Market Analysis & Forecast 2018-2023

CHAPTER 1 HORMONAL THERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Hormonal Therapy
1.2 Hormonal Therapy Market Segmentation by Type
  1.2.1 China Production Market Share of Hormonal Therapy by Oncologic hormone therapyn 2017
  1.2.1 Oncologic hormone therapy
  1.2.2 Hormone replacement therapy
  1.2.3 Type
1.3 Hormonal Therapy Market Segmentation by Application
  1.3.1 Hormonal Therapy Consumption Market Share by Application in 2017
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Hormonal Therapy (2013-2023)

CHAPTER 2 CHINA ECONOMIC IMPACT ON HORMONAL THERAPY INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Hormonal Therapy Industry

CHAPTER 3 CHINA HORMONAL THERAPY MARKET COMPETITION BY MANUFACTURERS

3.1 China Hormonal Therapy Production and Share by Manufacturers (2016 and 2017)
3.2 China Hormonal Therapy Revenue and Share by Manufacturers (2016 and 2017)
3.3 China Hormonal Therapy Average Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Hormonal Therapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Hormonal Therapy Market Competitive Situation and Trends
  3.5.1 Hormonal Therapy Market Concentration Rate
  3.5.2 Hormonal Therapy Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA HORMONAL THERAPY CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2013-2018)

4.1 China Hormonal Therapy Capacity, Production and Growth (2013-2018)
4.2 China Hormonal Therapy Revenue and Growth (2013-2018)
4.3 China Hormonal Therapy Production, Consumption, Export and Import (2013-2018)

CHAPTER 5 CHINA HORMONAL THERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Hormonal Therapy Production and Market Share by Type (2013-2018)
5.2 China Hormonal Therapy Revenue and Market Share by Type (2013-2018)
5.3 China Hormonal Therapy Price by Type (2013-2018)
5.4 China Hormonal Therapy Production Growth by Type (2013-2018)

CHAPTER 6 CHINA HORMONAL THERAPY MARKET ANALYSIS BY APPLICATION

6.1 China Hormonal Therapy Consumption and Market Share by Application (2013-2018)
6.2 China Hormonal Therapy Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA HORMONAL THERAPY MANUFACTURERS ANALYSIS

7.1 Bayer HealthCare Pharmaceuticals Inc.
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Business Overview
7.2 Besins Healthcare SA
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Business Overview
7.3 Hisamitsu Pharmaceutical Co. Inc.
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Business Overview
7.4 Noven Pharmaceuticals Inc., Mylan
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Business Overview
7.5 Novartis AG, Novo Nordisk A/S
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.5.4 Business Overview
7.6 Orion Corp.
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Business Overview
7.7 Pfizer Inc.
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Business Overview
7.8 company
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Business Overview
7.9 company
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
  7.9.4 Business Overview

CHAPTER 8 HORMONAL THERAPY MANUFACTURING COST ANALYSIS

8.1 Hormonal Therapy Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hormonal Therapy

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Hormonal Therapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hormonal Therapy Major Manufacturers in 2016
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA HORMONAL THERAPY MARKET FORECAST (2018-2023)

12.1 China Hormonal Therapy Production, Revenue Forecast (2018-2023)
12.2 China Hormonal Therapy Production, Consumption Forecast by Regions (2018-2023)
12.3 China Hormonal Therapy Production Forecast by Type (2018-2023)
12.4 China Hormonal Therapy Consumption Forecast by Application (2018-2023)
12.5 Hormonal Therapy Price Forecast (2018-2023)

CHAPTER 13 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Hormonal Therapy
Figure China Production Market Share of Hormonal Therapy by Oncologic hormone therapyn 2017
Table Hormonal Therapy Consumption Market Share by Application in 2017
Figure China Hormonal Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Table China Hormonal Therapy Capacity of Key Manufacturers (2016 and 2017)
Table China Hormonal Therapy Capacity Market Share of Key Manufacturers (2016 and 2017)
Figure China Hormonal Therapy Capacity of Key Manufacturers in 2016
Figure China Hormonal Therapy Capacity of Key Manufacturers in 2017
Table China Hormonal Therapy Production of Key Manufacturers (2016 and 2017)
Table China Hormonal Therapy Production Share by Manufacturers (2016 and 2017)
Figure 2015 Hormonal Therapy Production Share by Manufacturers
Figure 2016 Hormonal Therapy Production Share by Manufacturers
Table China Hormonal Therapy Revenue (Million USD) by Manufacturers (2016 and 2017)
Table China Hormonal Therapy Revenue Share by Manufacturers (2016 and 2017)
Table 2015 China Hormonal Therapy Revenue Share by Manufacturers
Table 2016 China Hormonal Therapy Revenue Share by Manufacturers
Table China Market Hormonal Therapy Average Price of Key Manufacturers (2016 and 2017)
Figure China Market Hormonal Therapy Average Price of Key Manufacturers in 2016
Table Manufacturers Hormonal Therapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Hormonal Therapy Product Type
Figure Hormonal Therapy Market Share of Top 3 Manufacturers
Figure Hormonal Therapy Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Hormonal Therapy Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
Figure Church & Dwight Hormonal Therapy Market Share (2013-2018)
Table Bayer HealthCare Pharmaceuticals Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer HealthCare Pharmaceuticals Inc. Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table Bayer HealthCare Pharmaceuticals Inc. Hormonal Therapy Market Share (2013-2018)
Table Besins Healthcare SA Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Besins Healthcare SA Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table Besins Healthcare SA Hormonal Therapy Market Share (2013-2018)
Table Hisamitsu Pharmaceutical Co. Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hisamitsu Pharmaceutical Co. Inc. Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table Hisamitsu Pharmaceutical Co. Inc. Hormonal Therapy Market Share (2013-2018)
Table Noven Pharmaceuticals Inc., Mylan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Noven Pharmaceuticals Inc., Mylan Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table Noven Pharmaceuticals Inc., Mylan Hormonal Therapy Market Share (2013-2018)
Table Novartis AG, Novo Nordisk A/S Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG, Novo Nordisk A/S Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table Novartis AG, Novo Nordisk A/S Hormonal Therapy Market Share (2013-2018)
Table Orion Corp. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Orion Corp. Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table Orion Corp. Hormonal Therapy Market Share (2013-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table Pfizer Inc. Hormonal Therapy Market Share (2013-2018)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table company 8 Hormonal Therapy Market Share (2013-2018)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Hormonal Therapy Production, Revenue, Price and Gross Margin (2013-2018)
Table company 9 Hormonal Therapy Market Share (2013-2018)
Figure Production Revenue Share of Hormonal Therapy by Type (2013-2018)
Figure 2015 Revenue Market Share of Hormonal Therapy by Type
Table China Hormonal Therapy Price by Type (2013-2018)
Figure China Hormonal Therapy Production Growth by Type (2013-2018)
Table China Hormonal Therapy Consumption by Application (2013-2018)
Table China Hormonal Therapy Consumption Market Share by Application (2013-2018)
Figure China Hormonal Therapy Consumption Market Share by Application in 2016
Table China Hormonal Therapy Consumption Growth Rate by Application (2013-2018)
Figure China Hormonal Therapy Consumption Growth Rate by Application (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hormonal Therapy
Figure Manufacturing Process Analysis of Hormonal Therapy
Figure Hormonal Therapy Industrial Chain Analysis
Table Raw Materials Sources of Hormonal Therapy Major Manufacturers in 2016
Table Major Buyers of Hormonal Therapy
Table Distributors/Traders List
Figure China Hormonal Therapy Capacity, Production and Growth Rate Forecast (2018-2023)
Figure China Hormonal Therapy Revenue and Growth Rate Forecast (2018-2023)
Table China Hormonal Therapy Production, Import, Export and Consumption Forecast (2018-2023)
Table China Hormonal Therapy Production Forecast by Type (2018-2023)
Table China Hormonal Therapy Consumption Forecast by Application (2018-2023)

COMPANIES MENTIONED

Bayer HealthCare Pharmaceuticals Inc. Besins Healthcare SA Hisamitsu Pharmaceutical Co. Inc. Noven Pharmaceuticals Inc., Mylan Novartis AG, Novo Nordisk A/S Orion Corp. Pfizer Inc.


More Publications